4
Changes in Ownership
Perspective Therapeutics, Inc. Filed Acc 0001437749-20-024716
CEO bought 68,000 shares at $0.38 ($25,534)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Woods Lori A CEO | 2020-11-30 | Purchase | +68,000 | $0.38 | $25,534 | 610,500 | I: show line 1 in the form |
| Open-market purchases · 68,000 sh · avg $0.38 · $25,534 | |||||||
Loading xslF345X03/rdgdoc.xml…